These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

313 related articles for article (PubMed ID: 32340868)

  • 1. Improving Vaccine-Induced Immunity: Can Baseline Predict Outcome?
    Tsang JS; Dobaño C; VanDamme P; Moncunill G; Marchant A; Othman RB; Sadarangani M; Koff WC; Kollmann TR
    Trends Immunol; 2020 Jun; 41(6):457-465. PubMed ID: 32340868
    [TBL] [Abstract][Full Text] [Related]  

  • 2. [Progress in research of influence of gene polymorphisms on immune response].
    Cao JQ; Li JX; Wang YY; Zhu FC
    Zhonghua Liu Xing Bing Xue Za Zhi; 2018 Nov; 39(11):1515-1518. PubMed ID: 30462964
    [TBL] [Abstract][Full Text] [Related]  

  • 3. OMIC Technologies and Vaccine Development: From the Identification of Vulnerable Individuals to the Formulation of Invulnerable Vaccines.
    Cotugno N; Ruggiero A; Santilli V; Manno EC; Rocca S; Zicari S; Amodio D; Colucci M; Rossi P; Levy O; Martinon-Torres F; Pollard AJ; Palma P
    J Immunol Res; 2019; 2019():8732191. PubMed ID: 31183393
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Genetic variation in the response to vaccination.
    Kimman TG; Vandebriel RJ; Hoebee B
    Community Genet; 2007; 10(4):201-17. PubMed ID: 17895626
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Measles and mumps vaccination as a model to investigate the developing immune system: passive and active immunity during the first year of life.
    Gans H; DeHovitz R; Forghani B; Beeler J; Maldonado Y; Arvin AM
    Vaccine; 2003 Jul; 21(24):3398-405. PubMed ID: 12850348
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Active and passive immunity, vaccine types, excipients and licensing.
    Baxter D
    Occup Med (Lond); 2007 Dec; 57(8):552-6. PubMed ID: 18045976
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Non-specific effects of vaccination: vaccines have non-specific (heterologous) effects.
    Shann F
    BMJ; 2005 Apr; 330(7495):844; author reply 844. PubMed ID: 15817557
    [No Abstract]   [Full Text] [Related]  

  • 8. The effects of vaccine timing on the efficacy of an acute eccentric exercise intervention on the immune response to an influenza vaccine in young adults.
    Campbell JP; Edwards KM; Ring C; Drayson MT; Bosch JA; Inskip A; Long JE; Pulsford D; Burns VE
    Brain Behav Immun; 2010 Feb; 24(2):236-42. PubMed ID: 19818846
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Molecular signatures of vaccine adjuvants.
    Olafsdottir T; Lindqvist M; Harandi AM
    Vaccine; 2015 Sep; 33(40):5302-7. PubMed ID: 25989447
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Identifying gnostic predictors of the vaccine response.
    Haining WN; Pulendran B
    Curr Opin Immunol; 2012 Jun; 24(3):332-6. PubMed ID: 22633886
    [TBL] [Abstract][Full Text] [Related]  

  • 11. [Features of formation of postvaccinal immunity in the population of one-company towns and rural settlements 1].
    Boev MV; Moev VM; Borisov SD
    Gig Sanit; 2012; (3):19-21. PubMed ID: 23088113
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Patient Subtyping Analysis of Baseline Multi-omic Data Reveals Distinct Pre-immune States Predictive of Vaccination Responses.
    Bayrak CS; Forst C; Jones DR; Gresham D; Pushalkar S; Wu S; Vogel C; Mahal L; Ghedin E; Ross T; García-Sastre A; Zhang B
    bioRxiv; 2024 Jan; ():. PubMed ID: 38328256
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Sustainable vaccine development: a vaccine manufacturer's perspective.
    Rappuoli R; Hanon E
    Curr Opin Immunol; 2018 Aug; 53():111-118. PubMed ID: 29751212
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Intranasal Immunization with DOTAP Cationic Liposomes Combined with DC-Cholesterol Induces Potent Antigen-Specific Mucosal and Systemic Immune Responses in Mice.
    Tada R; Hidaka A; Iwase N; Takahashi S; Yamakita Y; Iwata T; Muto S; Sato E; Takayama N; Honjo E; Kiyono H; Kunisawa J; Aramaki Y
    PLoS One; 2015; 10(10):e0139785. PubMed ID: 26440657
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Predicting vaccine responsiveness.
    Boyd SD; Jackson KJL
    Cell Host Microbe; 2015 Mar; 17(3):301-307. PubMed ID: 25766292
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Immunosenescence and vaccine failure in the elderly: strategies for improving response.
    Boraschi D; Italiani P
    Immunol Lett; 2014 Nov; 162(1 Pt B):346-53. PubMed ID: 24960535
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Transcriptional profiling technology for studying vaccine responses: an untapped goldmine.
    Flanagan KL; Noho-Konteh F; Ghazal P; Dickinson P
    Methods; 2013 May; 60(3):269-74. PubMed ID: 23578546
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Understanding modern-day vaccines: what you need to know.
    Vetter V; Denizer G; Friedland LR; Krishnan J; Shapiro M
    Ann Med; 2018 Mar; 50(2):110-120. PubMed ID: 29172780
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Can We Improve Vaccine Efficacy by Targeting T and B Cell Repertoire Convergence?
    Fink K
    Front Immunol; 2019; 10():110. PubMed ID: 30814993
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Vaccination against hepatitis B virus in highly endemic areas: waning vaccine-induced immunity and the need for booster doses.
    Edmunds WJ; Medley GF; Nokes DJ
    Trans R Soc Trop Med Hyg; 1996; 90(4):436-40. PubMed ID: 8882200
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 16.